
94% of researchers rate our articles as excellent or good
Learn more about the work of our research integrity team to safeguard the quality of each article we publish.
Find out more
REVIEW article
Front. Endocrinol.
Sec. Reproduction
Volume 16 - 2025 | doi: 10.3389/fendo.2025.1386716
The final, formatted version of the article will be published soon.
You have multiple emails registered with Frontiers:
Please enter your email address:
If you already have an account, please login
You don't have a Frontiers account ? You can register here
Assisted reproductive technologies (ART) and cryobiology advances over the past decades have offered hope to cancer patients who might not otherwise be able to have biological offspring due to the toxic nature of therapies that may lead to subfertility or infertility. Fertility preservation (FP) for youths with gender dysphoria (GD) poses an additional set of complications and obstacles because of the use of medications which block normal pubertal development such as gonadotropin-releasing hormone analogues (GnRHa) and medications which directly alter the genital tract such as cross sex hormones. Here we review the current state of knowledge and ethical concerns with FP focusing on issues when FP is used during adolescent and preadolescent reproductive development in the context of cancer and gender dysphoria treatment. Particularly for youths with GD, very little evidence-based research has been performed and much remains unknown with respect to long term harms to reproductive health and the ultimate success of FP and conception.
Keywords: Reproduction, Pediatrics, Infertility, Puberty, estrogen, Testosterone, transgender
Received: 15 Feb 2024; Accepted: 19 Mar 2025.
Copyright: © 2025 Laidlaw, Lahl and Thompson. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
* Correspondence:
Michael Laidlaw, Other, Rocklin, United States
Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.
Research integrity at Frontiers
Learn more about the work of our research integrity team to safeguard the quality of each article we publish.